申请人:RAPPELER CO., LTD.
公开号:US20230099567A1
公开(公告)日:2023-03-30
Provided are a novel compound exhibiting the effect of treating, preventing or ameliorating lymphedema, and a composition including the same as an active ingredient, and may be applied as a medicament product, functional food or food supplement, or cosmetics. The compound used as an active ingredient compound according to the disclosure exhibits a remarkable ameliorating effect on lymphedema in various aspects such as TNFα production inhibitory activity, metabolic stability, solubility, and blood exposure.
提供了一种新化合物,具有治疗、预防或改善淋巴水肿的作用,以及包含该化合物作为活性成分的组合物,可用作药物产品、功能性食品或食品补充剂或化妆品。根据公开披露,该化合物作为活性成分化合物,在TNFα产生抑制活性、代谢稳定性、溶解度和血液暴露等方面具有显著的改善淋巴水肿的作用。